* Flex Pharma initiates phase 2 efficacy study in multiple
sclerosis

Source text for Eikon:
Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

The post BRIEF-Flex Pharma initiates phase 2 efficacy study appeared first on NASDAQ.